The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 17,901–18,000 of 31,469
de Luis, D. A., Calvo, S. G., Pacheco, D., Ovalle, H. F., & Aller, R. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.06.006 · Cited by 15
Macías‐González, M., Martín‐Núñez, G. M., Garrido‐Sánchez, L., García‐Fuentes, E., Tinahones, F. J., & Morcillo, S. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.06.011 · Cited by 15
Meng, H., Matthan, N. R., Fried, S. K., Berciano, S., Walker, M. E., Galluccio, J. M., & Lichtenstein, A. H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00667 · Cited by 17
Alterations in branched-chain amino acid kinetics in nonobese but insulin-resistant Asian men
Tan, H. C., Hsu, J. W.-C., Khoo, C. M., Tai, E. S., Sidney, Y., Chacko, S. K., Lai, O. F., & Jahoor, F. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy208 · Cited by 15
Li, Z., Danchun, L., Zhang, H., Zhang, H., Chen, X.-Z., & Sun, J. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/7925842 · Cited by 15
Li, T. T., Tan, T.-B., Hou, H. Q., & Zhao, X. Y. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0901-7 · Cited by 15
Mac‐Marcjanek, K., Zieleniak, A., Żurawska-Kliś, M., Cypryk, K., Woźniak, L. A., & Wójcik, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123826 · Cited by 15
Landi, F., Martone, A. M., Salini, S., Zazzara, M. B., Calvani, R., Marzetti, E., Nesci, A., Giorgio, A. D., Giupponi, B., Santoro, L., et al. (2019) · BioMed Research International · doi:10.1155/2019/1970878 · Cited by 15
Cardiorespiratory fitness is associated with inflammation and physical activity in HIV+ adults
Webel, A. R., Jenkins, T. L., Vest, M., Oliveira, V. H. F., Longenecker, C. T., Liu, J., Currie, J., Sattar, A., & Josephson, R. (2019) · AIDS · doi:10.1097/qad.0000000000002154 · Cited by 16
Comparative study of overweight and obese patients with nonalcoholic fatty liver disease
Aller, R., Gómez, B. B., Sigüenza, R., Fernández‐Rodríguez, C., Fernández, N., Antolín, B., Dur�, M., Pina, M. J. B., Lorenzo, S., García, C., et al. (2019) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2019.5926/2018 · Cited by 15
sRAGE and early signs of cardiac target organ damage in mild hypertensives
Maresca, A. M., Guasti, L., Bozzinì, S., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0821-5 · Cited by 15
Comparisons of different indices of low muscle mass in relationship with cardiometabolic disorder
Kim, J. Y., Oh, S., Park, H. Y., Jun, J. H., & Kim, H. J. (2019) · Scientific Reports · doi:10.1038/s41598-018-37347-3 · Cited by 17
Iron Status and Metabolically Unhealthy Obesity in Prepubertal Children
Suárez‐Ortegón, M. F., Echeverri, I., Prats‐Puig, A., Bassols, J., Carreras‐Badosa, G., López‐Bermejo, A., & Fernández‐Real, J. M. (2019) · Obesity · doi:10.1002/oby.22425 · Cited by 18
Cayres, S. U., Werneck, A. O., Urban, J. B., Turi‐Lynch, B. C., Barbosa, M. F., & Fernandes, R. A. (2019) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13418 · Cited by 15
Zhang, J.-L., Li, H., Bai, N., Xu, Y., Song, Q., Zhang, L., Wu, G., Chen, S., Hou, X., Wang, C., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01018-5 · Cited by 16
Visceral Fat Accumulation Is Associated with Asthma in Patients with Type 2 Diabetes
Murakami, D., Anan, F., Masaki, T., Umeno, Y., Shigenaga, T., Eshima, N., & Nakagawa, T. (2019) · Journal of Diabetes Research · doi:10.1155/2019/3129286 · Cited by 13
Effects of TCF7L2 rs7903146 variant on metformin response in patients with type 2 diabetes
Dujić, T., Bego, T., Malenica, M., Velija-Ašimi, Z., Ahlqvist, E., Groop, L., Pearson, E. R., Čaušević, A., & Semiz, S. (2019) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2019.4181 · Cited by 15
A novel biomarker of cardiometabolic pathology in schizophrenia?
Lee, E., Sears, D. D., Liu, J., Jin, H., Tu, X. M., Eyler, L. T., & Jeste, D. V. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.06.011 · Cited by 16
Khan, S. H., Khan, A. N., Chaudhry, N., Anwar, R., Fazal, N., & Tariq, M. (2019) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-019-0439-5 · Cited by 15
Arpón, A., Santos, J. L., Milagro, F. I., Cataldo, L. R., Bravo, C., Riezu‐Boj, J. I., & Martínez, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122928 · Cited by 17
Casella-Mariolo, J. R., Castagneto‐Gissey, L., Angelini, G., Zoli, A., Marini, P., Bornstein, S. R., Pournaras, D. J., Rubino, F., le Roux, C. W., Mingrone, G., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.069 · Cited by 15
Cai, J., Nuli, R., Zhang, Y., Zhang, Y., Abudusemaiti, M., Kadeer, A., Tian, X., & Xiao, H. (2019) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.65.362 · Cited by 16
Dong, X., Zhao, S.-X., Xu, B.-Q., et al. (2019) · Toxicology Research · doi:10.1039/c9tx00191c · Cited by 15
Magaña‐Gómez, J. A., Moreno-Mascareño, D., Angulo‐Rojo, C., et al. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2019.0113 · Cited by 15
Zhang, X., Martin, R. M., Oken, E., Aris, I. M., Yang, S., & Kramer, M. S. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz234 · Cited by 15
Soft Drinks Consumption and the Risk of Nonalcoholic Fatty Liver Disease.
Siddiqi, Z., Karoli, R., Fatima, J., Khanduri, S., Varshneya, S., & Ahmad, S. S. (2017) · PubMed · Cited by 16
Zupo, R., Castellana, F., Boninfante, B., Lampignano, L., Lattanzio, A., Sardone, R., Giannelli, G., & Pergola, G. D. (2019) · Nutrients · doi:10.3390/nu11122970 · Cited by 15
Therapeutic potential of metformin in normal glucose tolerant persons with metabolic syndrome
Kamenova, P. (2020) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2019.1711184 · Cited by 14
Atteia, H. H., Alzahrani, S., El-Sherbeeny, N. A., Youssef, A. M., Farag, N. E., Mehanna, E. T., Elhawary, R., Ibrahim, G. A., Elmistekawy, A., & Zaitone, S. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00942 · Cited by 15
Serum Caspase-1 levels in women with polycystic ovary syndrome
Çabuş, Ü., Kabukçu, C., Fenkçi, S. M., et al. (2020) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2020.01.007 · Cited by 15
Lima, R. A., Desoyé, G., Simmons, D. S., Devlieger, R., Galjaard, S., Corcoy, R., Adelantado, J. M., Dunne, F., Harreiter, J., Kautzky‐Willer, A., et al. (2020) · Pediatric Obesity · doi:10.1111/ijpo.12628 · Cited by 14
Ma, C., Liu, Y., He, S., Zeng, J., Li, P., Ma, C., Ping, F., Zhang, H., Xu, L., Li, W., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00536 · Cited by 15
Wu, P., Tsai, S., Lee, C., Lin, W., Chin, Y., Huang, H.-L., Seal, D. W., Chen, T., & Lee, C. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00745-1 · Cited by 15
de Almeida-Pititto, B., Dualib, P. M., Jordão, M. C., Fonseca, M. I. H., Jones, S. R., Blaha, M. J., Toth, P. P., Santos, R. D., Benseñor, I. M., Ferreira, S. R. G., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108747 · Cited by 15
Effects of Totum-63 on glucose homeostasis and postprandial glycemia: a translational study
Chavanelle, V., Otero, Y. F., Joubioux, F. L., Ripoche, D., Bargetto, M., Vluggens, A., Montaurier, C., Pickering, G., Ducheix, G., Dubray, C., et al. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00629.2020 · Cited by 15
Intraperitoneal Fat and Insulin Resistance in Obese Adolescents
Glaser Pediatric Research Network Obesity Study Group (2009) · Obesity · doi:10.1038/oby.2009.261 · Cited by 15
Inflammatory markers and Lp(a) levels as cardiovascular risk factors in androgenetic alopecia
Vayá, A., Sarnago, A., Ricart, J. M., et al. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-141913 · Cited by 15
Hashemipour, S., Esmailzadehha, N., Hamid, H., Oveisi, S., Yakhchaliha, P., & Ziaee, A. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0302-y · Cited by 14
Florez, H. J., Ryder, E., Campos, G., Fernández, V., Morales, L. M., Valbuena, H., Rincón, E., Gómez, M. E., & Raleigh, X. (1999) · PubMed · Cited by 15
Kirkby, J., Metcalf, B. S., Jeffery, A., O'Riordan, C. F., Perkins, J., Voss, L. D., & Wilkin, T. J. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.430 · Cited by 15
Shiba, C., Shiba, T., Takahashi, M., Hori, Y., & Maeno, T. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2898-6 · Cited by 15
Effect of Beta-Blockers on Insulin Resistance in Patients With Dilated Cardiomyopathy
Hara, Y., Hamada, M., Shigematsu, Y., Ohtsuka, T., Ogimoto, A., & Higaki, J. (2003) · Circulation Journal · doi:10.1253/circj.67.701 · Cited by 15
Magkos, F., Fabbrini, E., McCrea, J., Patterson, B. W., Eagon, J. C., & Klein, S. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01191.x · Cited by 16
Rapid significant weight loss and regional lipid deposition: Implications for insulin sensitivity
Wahlroos, S., Phillips, M. L., Lewis, M., Kow, L., Toouli, J., Slavotinek, J., Valentine, R., & Thompson, C. H. (2007) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2006.08.002 · Cited by 15
Maegawa, H., Nishio, Y., NAKAO, K., Ugi, S., MAEDA, K., Uzu, T., & Kashiwagi, A. (2007) · Endocrine Journal · doi:10.1507/endocrj.k06-203 · Cited by 15
Endothelial haemostatic markers in members of families with familial combined hyperlipidemia
Karásek, D., Vaverková, H., Halenka, M., Slavík, L., & Novotný, D. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.02.011 · Cited by 15
Daily Marathon Running for a Week—The Biochemical and Body Compositional Effects of Participation
Karstoft, K., Solomon, T. P. J., Laye, M. J., et al. (2013) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0b013e318289e39d · Cited by 15
Insulin Resistance (HOMA) in Relation to Plasma Cortisol, IGF-I and IGFBP-3
Bleicher, M., Högel, J., Wudy, S. A., Wabitsch, M., Homoki, J., Sorgo, W., & Heinze, E. (2002) · Hormone Research in Paediatrics · doi:10.1159/000066266 · Cited by 15
Angelico, F., Francioso, S., Ben, M. D., et al. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04055.x · Cited by 15
Association of Ob-R gene polymorphism and insulin resistance in Japanese men
Takahashi-Yasuno, A., Masuzaki, H., Miyawaki, T., Matsuoka, N., Ogawa, Y., Hayashi, T., Hosoda, K., Yoshimasa, Y., Inoue, G., & Nakao, K. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.012 · Cited by 15
Effect of Family History of Type 2 Diabetes on White Blood Cell Count in Adult Women
Pannacciulli, N., Giorgino, F., Martina, R. A., Resta, O., GIORGINO, R., & Pergola, G. D. (2003) · Obesity Research · doi:10.1038/oby.2003.169 · Cited by 15
Diagnosis of Insulin Resistance
Martinez, F. J., Villa, E., Serrano, J., & García‐Robles, R. (1993) · Drugs · doi:10.2165/00003495-199300462-00026 · Cited by 15
Carlson, O. D., David, J. D., Schrieder, J. M., Muller, D. C., Jang, H.-J., Kim, B.-J., & Egan, J. M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.009 · Cited by 16
Voruganti, V. S., Göring, H. H. H., Diego, V. P., et al. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e31813cbf02 · Cited by 15
Ybarra, J., Sánchez-Hernández, J., Pou, J. M., Fernández, S., Gich, I. J., Ordóñez‐Llanos, J., Jurado, J., de Leiva, A., & Pérez, A. (2005) · Global Heart · doi:10.1016/j.precon.2005.05.001 · Cited by 13
Determinants of Insulin Sensitivity in Chronic Heart Failure
Sabelis, L. W. E., Senden, P. J., Zonderland, M. L., van de Wiel, A., Wielders, J. P. M., Huisveld, I. A., van Haeften, T. W., & Mosterd, W. L. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00156-9 · Cited by 15
Stellingwerff, T., Boon, H., Gijsen, A. P., Stegen, J. H. C. H., Kuipers, H., & van Loon, L. J. C. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000272960.60101.aa · Cited by 15
Waib, P., Gonçalves, M. I., & Barrile, S. (2011) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00393.x · Cited by 12
Microalbuminuria, a parameter independent of metabolic influences in hypertensive men
Pedrinelli, R., Dell’Omo, G., Penno, G., Bello, V. D., Giorgi, D., Pellegrini, G., Prato, S. D., & Mariani, M. (2003) · Journal of Hypertension · doi:10.1097/00004872-200306000-00017 · Cited by 15
Iwai, H., Ohno, Y., & Aoki, N. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.673 · Cited by 15
Yamada, Y., Noborisaka, Y., Ishizaki, M., Tsuritani, I., Honda, R., & Yamada, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001678 · Cited by 15
Total and acylated ghrelin in liver cirrhosis: Correlation with clinical and nutritional status
El‐Shehaby, A., Obaia, E. M., Alwakil, S., & Hiekal, A. A. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365511003763349 · Cited by 15
Ban, Y., Koba, S., Tsunoda, F., Yokota, Y., Ezumi, H., Kondo, T., Suzuki, H., & Katagiri, T. (2006) · Circulation Journal · doi:10.1253/circj.70.393 · Cited by 15
Metabolic Syndrome Is not a Risk Factor for Kidney Dysfunction in Obese Non‐diabetic Subjects
Gatti, A., Morini, E., Cosmo, S. D., et al. (2008) · Obesity · doi:10.1038/oby.2007.59 · Cited by 15
Suzuki, H., Fukushima, M., Usami, M., et al. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.11.008 · Cited by 15
Body fat distribution, serum glucose, lipid and insulin response to meals in Alström syndrome
Paisey, R., Hodge, D. O., & Williams, K. (2008) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00866.x · Cited by 15
Genelhu, V. A., Celoria, B. M. J., Pimentel, M. M. G., Duarte, S. F. P., Cabello, P. H., & Francischetti, E. A. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.7 · Cited by 15
Makino, H., Doi, K., Hiuge, A., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.08.014 · Cited by 15
Liver and Other Gastrointestinal Cancers Are Frequent in Mexican Americans
Garza, A. L., Vatcheva, K. P., Pan, J., et al. (2015) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-015-0104-0 · Cited by 15
Melzi, R., Maffi, P., Nano, R., Sordi, V., Mercalli, A., Scavini, M., Secchi, A., Bonifacio, E. E., & Piemonti, L. (2009) · Islets · doi:10.4161/isl.1.1.8881 · Cited by 15
Canivell, S., Ruano, E. G., Sisó‐Almirall, A., Kostov, B., Paz, L. G., Fernández‐Rebollo, E., Hanzu, F. A., Párrizas, M., Novials, A., & Gomis, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075474 · Cited by 16
A computational model of the human glucose-insulin regulatory system
Shiang, K., & Kandeel, F. (2010) · Journal of Biomedical Research · doi:10.1016/s1674-8301(10)60048-6 · Cited by 17
Rouen, P. A., Lukacs, J. L., & Reame, N. E. (2010) · Biological Research For Nursing · doi:10.1177/1099800410365368 · Cited by 14
Amoah, A. G. B., Schuster, D. P., Gaillard, T. R., & Osei, K. (2003) · Diabetologia · doi:10.1007/s00125-003-1130-8 · Cited by 16
Brouwers, M. C. G. J., van Greevenbroek, M. M. J., Troutt, J. S., Freeman, A. B., Lu, A., Schaper, N. C., Konrad, R. J., & Stehouwer, C. D. A. (2011) · Clinical Science · doi:10.1042/cs20110129 · Cited by 15
Unsaturated fatty acids and insulin resistance in childhood obesity
Toledo, K., Aranda, M., Sylvia Asenjo, M., Sáez, K. L., & Bustos, P. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0281 · Cited by 16
Katulanda, P., Groves, C. J., Barrett, A. M., et al. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02377.x · Cited by 15
Self-citationRyder, E., Gómez, M. E., Fernández, V., Campos, G., Morales, L. M., Valbuena, H., & Raleigh, X. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00282-6 · Cited by 15
Shortened Blood Coagulation Times in Genetically Obese Rats and Diet-Induced Obese Mice
Kaji, N., Nagakubo, D., HASHIDA, S.-I., et al. (2013) · Journal of Veterinary Medical Science · doi:10.1292/jvms.13-0029 · Cited by 15
Insulin resistance without obesity induced by cotton pellet granuloma in mice
Wu, H., Chang, C. K., Tsao, C.-W., Wen, Y.-J., Ling, S.-M., Cheng, K., Chang, C.-J., & Cheng, J. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2008.161 · Cited by 15
Curtis, L. H., Hammill, B. G., Bethel, M. A., Anstrom, K. J., Liao, L., Gottdiener, J. S., & Schul, K. A. (2007) · Current Medical Research and Opinion · doi:10.1185/030079908x253573 · Cited by 15
Avaliação do efeito hipoglicemiante de Cissus sicyoides em estudos clínicos fase II
Santos, H. B., Modesto-Filho, J., Diniz, M. D. F. F. M., de Vasconcelos, T. H. C., Pereira, F. S. D. B., Ramalho, J. D. A., Dantas, J. G., & Santos, E. B. (2008) · Revista Brasileira de Farmacognosia · doi:10.1590/s0102-695x2008000100014 · Cited by 15
Kim, H., Lee, S.-K., Suh, C. J., Yoon, H. J., Lee, K., Park, H.-Y., & Kang, M.-H. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00199-7 · Cited by 15
Kim, J. W., Lee, M. H., Park, J. E., Yoon, T. K., Lee, W. S., & Shim, S. H. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.12.008 · Cited by 15
Nguyen, Q. M., Srinivasan, S. R., Xu, J.-H., Chen, W., & Berenson, G. S. (2008) · Metabolism · doi:10.1016/j.metabol.2008.04.011 · Cited by 14
Síndrome metabólico, resistencia a la insulina y metabolismo tisular
de Morentin, B. E. M., Rodríguez, M. C., & Martínez, J. A. (2003) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(03)74546-x · Cited by 15
Grandi, A. M., Nicolini, E., Giola, M., Gianni, M., Maresca, A. M., Marchesi, C., Guasti, L., Balsamo, M. L., Venco, A., & Grossi, P. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.81 · Cited by 15
Öncül, O., Top, C., & Çavuþlu, Þ. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.937 · Cited by 15
Tanaka, Y., Takahashi, T., & Tamori, Y. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0210 · Cited by 15
Ward, A. M. V., Syddall, H. E., Wood, P. J., Dennison, E. M., & Phillips, D. I. W. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.008 · Cited by 16
Metabolic response to oral lipid overload in diabetes and impaired glucose tolerance
de Ugarte, M. T. O., Portal, V. L., Dias, A., & Schaan, B. D. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.011 · Cited by 15
Trento, M., Kucich, C., Tibaldi, P., Gennari, S. M., Tedesco, S., Balbo, M. L., Arvat, E., Cavallo, F., Ghigo, E., & Porta, M. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346660 · Cited by 15
Pijl, H., van Loon, B. J. P., Toornvliet, A. C., Radder, J. K., Onkenhout, W., Frölich, M., & Meinders, A. E. (1994) · Metabolism · doi:10.1016/0026-0495(94)90208-9 · Cited by 15
Bathula, R., Francis, D. P., Hughes, A. D., & Chaturvedi, N. (2008) · Clinical Autonomic Research · doi:10.1007/s10286-008-0463-2 · Cited by 15
Fat mass largely contributes to insulin mediated glucose uptake in morbidly obese subjects
Gniuli, D., Gissey, G. C., Iaconelli, A., Leccesi, L., & Mingrone, G. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.99 · Cited by 15
Beauvieux, M.-C., Quesson, B., Thiaudière, E., Gallis, J., Canioni, P., & Gin, H. (1999) · Diabetes · doi:10.2337/diabetes.48.2.327 · Cited by 15
Validation of Steady-State Insulin Sensitivity Indices in Chronic Kidney Disease
Crutchlow, M. F., Robinson, B. M., Pappachen, B., Wimmer, N. J., Cucchiara, A. J., Cohen, D. L., & Townsend, R. R. (2007) · Diabetes Care · doi:10.2337/dc06-2630 · Cited by 15
Multimodality vascular imaging in CKD: divergence of risk between measured parameters
Petchey, W. G., Hawley, C. M., Johnson, D. W., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr397 · Cited by 15
Hu, X., Ma, X., Pan, X., et al. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12467 · Cited by 15
Blom, W. A. M., de Graaf, C., Lluch, A., Stafleu, A., Schaafsma, G., & Hendriks, H. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.01.016 · Cited by 15
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
